Form 4: Abbott Laboratories VP and Controller, John A. McCoy, Jr., Reports Stock Transactions

John A. McCoy, Jr., Vice President and Controller of Abbott Laboratories, reports the disposition and acquisition of company stock.

Summary

• On February 28, 2025, John A. McCoy, Jr., Vice President and Controller of Abbott Laboratories, disposed of 1,096 common shares at a price of $135.87.
• On March 3, 2025, McCoy sold 562 common shares at a price of $138.17.
• Following these transactions, McCoy directly owns 21,061 common shares and indirectly owns 57 shares through a Profit Sharing Trust.

Sentiment

Score: 5

Explanation: This is a routine disclosure of stock transactions by a company insider. The sentiment is neutral as it simply reports facts without indicating positive or negative implications for the company's performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders, like officers and directors, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's performance and future prospects.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the actions of company leadership.
• The impact on employees, customers, suppliers, and creditors is likely minimal, as these are standard stock transactions.

Key Dates